Startups
IMCAS started in 1995, in Paris, France, as a congress dedicated to plastic surgeons and dermatologists. Since its conception, IMCAS has sought to bridge the knowledge vacuum between Plastic and Reconstructive Surgery and Dermatology, thereby generating a synergetic and mutually reinforcing interface among these two fields.
Overview
Location
France, Ile-de-France, Paris
Phone
+33 1 40 73 82 82
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 7, 2026 | CHANDO Presents Decade-Long Skin Brightening Research at IMCAS | Research Introduces 577 Epigenetic Mechanism for Asian Skin SHANGHAI, Feb. 7, 2026 /PRNewswire/ -- The IMCAS World Congress 2026, an internationally recognized forum for aesthetic medicine and clinical research, opened on January 31 in Pari... |
| Feb 2, 2026 | High-end Aesthetic Brand ‘Lorient’ Gains Global Prestige at IMCAS 2026 | Lorient, a premium aesthetic brand, announced that it has drawn global attention at the 27th IMCAS World Congress 2026 in Paris, attracting over 15,000 professionals and demonstrating its leadership in aesthetic innovation. This press relea... |
| Jan 26, 2026 | CO2Lift® Debuts CARBOXY COUTURE in Paris During IMCAS and Couture Fashion Week | An immersive Paris experience uniting regenerative science, fashion, and recovery through education, design, and global medical leadership. CARBOXY COUTURE reframes recovery as essential care, uniting regenerative science, design, and educa... |
| Aug 4, 2025 | Aphranel® shines in IMCAS China 2025 as Platinum Sponsor | SHANGHAI, Aug. 4, 2025 /PRNewswire/ -- Aphranel, China's leading innovator of regenerative aesthetics medicine, recently made waves at IMCAS China 2025 with its 36㎡ platinum sponsorship booth, hosted a 60-minute scientific symposium and 30-... |
| Dec 19, 2024 | Caliway to Present CBL-514 Phase 2b Study Results for Subcutaneous Fat Reduction at IMCAS 2025 in Paris | The findings from the CBL-0204 Phase 2b clinical trial have been selected for presentation at IMCAS, the premier global congress in aesthetic medicine. The data will be highlighted in both the 2025 focus session on advances in fat reduction... |
| Jul 12, 2024 | SBC Medical Group Co., Ltd. Presented at the international academic conference “IMCAS Asia 2024” to be hel d in June 2024 | [SBC Medical Group Co., Ltd.] Presented at the international academic conference “IMCAS Asia 2024” to be held in June 2024 *SBC Medical Group Co., Ltd.* Press release: July 12, 2024 ** Presented at the international academic conference “IMC... |
| Jul 12, 2024 | SBC Medical Group Co., Ltd. Presented at the international academic conference “IMCAS Asia 2024” to be hel d in June 2024 | |
| Dec 27, 2023 | Caliway to Present CBL-514 Phase 2 Study Results for Subcutaneous Fat Reduction at IMCAS 2024 | CBL-514 Phase 2 Study Results for local fat reduction demonstrated 85.7% and 76.2% of participants lost at least 150mL and 200mL of abdominal subcutaneous fat in the treated area after receiving CBL-514 treatment(s). NEW TAIPEI CITY, Dec. 2... |
| Jan 24, 2023 | ANTEAGE HOSTS 3 SESSIONS AT IMCAS IN PARIS TO HIGHLIGHT THE FUTURE OF REGENERATIVE AESTHETICS | AnteAGE will host three sessions to hear from industry leaders about their cutting-edge solutions to address aging for flawless skin, hair and vaginal health. IRVINE, CALIFORNIA, UNITED STATES, January 24, 2023 /EINPresswire.com/ -- As a pi... |
Show more
Reviews 0
FAQ about IMCAS
What has the press written about IMCAS?
Parsers VC has collected 12 articles mentioning IMCAS, among them “CHANDO Presents Decade-Long Skin Brightening Research at IMCAS” (Feb 7, 2026) and “High-end Aesthetic Brand ‘Lorient’ Gains Global Prestige at IMCAS 2026” (Feb 2, 2026).
Is IMCAS still active?
Yes, IMCAS is active; its latest activity on Parsers VC dates from Aug 28, 2026.